DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,367 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $319,000 | +0.9% | 2,209 | 0.0% | 0.13% | 0.0% |
| Q2 2019 | $316,000 | +8.2% | 2,209 | 0.0% | 0.13% | +11.9% |
| Q1 2019 | $292,000 | +27.0% | 2,209 | -1.0% | 0.12% | +24.2% |
| Q4 2018 | $230,000 | +2.7% | 2,231 | 0.0% | 0.10% | +3.3% |
| Q3 2018 | $224,000 | -10.8% | 2,231 | -12.2% | 0.09% | -3.2% |
| Q2 2018 | $251,000 | +4.1% | 2,541 | +3.3% | 0.10% | +6.7% |
| Q1 2018 | $241,000 | -13.3% | 2,460 | -17.7% | 0.09% | -11.9% |
| Q4 2017 | $278,000 | +14.9% | 2,990 | +6.1% | 0.10% | +7.4% |
| Q3 2017 | $242,000 | -24.4% | 2,817 | -25.6% | 0.09% | -29.3% |
| Q2 2017 | $320,000 | +117.7% | 3,788 | +120.7% | 0.13% | +107.8% |
| Q1 2017 | $147,000 | -37.4% | 1,716 | -43.1% | 0.06% | -40.7% |
| Q4 2016 | $235,000 | +74.1% | 3,016 | +75.8% | 0.11% | +71.4% |
| Q3 2016 | $135,000 | -22.4% | 1,716 | 0.0% | 0.06% | -25.0% |
| Q2 2016 | $174,000 | +7.4% | 1,716 | 0.0% | 0.08% | +7.7% |
| Q1 2016 | $162,000 | -30.8% | 1,716 | -32.1% | 0.08% | -25.0% |
| Q4 2015 | $234,000 | – | 2,528 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |